Nutraceutical International Corp (NUTR) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
1400 KEARNS BOULEVARD PARK CITY, UT 84060 |
| State of Incorp. | DE |
| Fiscal Year End | September 30 |
| Industry (SIC) | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 6/30/2017 Q3 | 3/31/2017 Q2 | 12/31/2016 Q1 | 9/30/2016 Q4 | 6/30/2016 Q3 | 3/31/2016 Q2 | 12/31/2015 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 4,183 | 6,145 | 6,330 | 6,803 | 3,573 | 4,162 | 5,344 | ||
| Cash and cash equivalents | 4,183 | 6,145 | 6,330 | 6,803 | 3,573 | 4,162 | 5,344 | ||
| Receivables | 20,993 | 20,648 | 17,975 | 17,680 | 20,577 | 19,277 | 18,365 | ||
| Inventory, net of allowances, customer advances and progress billings | 68,558 | 65,300 | 65,910 | 63,923 | 63,945 | 61,491 | 61,843 | ||
| Inventory | 68,558 | 65,300 | 65,910 | 63,923 | 63,945 | 61,491 | 61,843 | ||
| Deferred tax assets | 1,250 | 1,257 | 1,260 | 1,243 | 1,233 | 1,169 | 1,176 | ||
| Other undisclosed current assets | 6,085 | 3,643 | 4,273 | 4,217 | 3,413 | 3,715 | 3,899 | ||
| Total current assets: | 101,069 | 96,993 | 95,748 | 93,866 | 92,741 | 89,814 | 90,627 | ||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 82,184 | 82,242 | 82,314 | 83,048 | 83,399 | 83,460 | 77,908 | ||
| Intangible assets, net (including goodwill) | 66,844 | 51,416 | 52,280 | 53,202 | 54,115 | 55,073 | 55,576 | ||
| Goodwill | 38,582 | 30,925 | 30,925 | 30,925 | 30,925 | 30,925 | 30,925 | ||
| Intangible assets, net (excluding goodwill) | 28,262 | 20,491 | 21,355 | 22,277 | 23,190 | 24,148 | 24,651 | ||
| Other noncurrent assets | 1,324 | 1,367 | 1,398 | 1,429 | 1,582 | 1,613 | 1,632 | ||
| Deferred tax assets, net | 5,037 | 4,587 | 4,465 | 4,310 | 4,758 | 4,555 | 3,473 | ||
| Total noncurrent assets: | 155,389 | 139,612 | 140,457 | 141,989 | 143,854 | 144,701 | 138,589 | ||
| TOTAL ASSETS: | 256,458 | 236,605 | 236,205 | 235,855 | 236,595 | 234,515 | 229,216 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 22,971 | 20,127 | 20,385 | 20,165 | 21,215 | 20,712 | 17,663 | ||
| Accounts payable | 16,372 | 15,206 | 15,665 | 12,696 | 14,098 | 13,915 | 13,211 | ||
| Accrued liabilities | 6,599 | 4,921 | 4,720 | 7,469 | 7,117 | 6,797 | 4,452 | ||
| Total current liabilities: | 22,971 | 20,127 | 20,385 | 20,165 | 21,215 | 20,712 | 17,663 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 50,500 | 36,500 | 39,500 | 43,500 | 46,000 | 47,500 | 48,000 | ||
| Long-term debt, excluding current maturities | 50,500 | 36,500 | 39,500 | 43,500 | 46,000 | 47,500 | 48,000 | ||
| Liabilities, other than long-term debt | 750 | 2 | 2 | 200 | 192 | 184 | 178 | ||
| Other liabilities | 750 | 2 | 2 | 200 | 192 | 184 | 178 | ||
| Total noncurrent liabilities: | 51,250 | 36,502 | 39,502 | 43,700 | 46,192 | 47,684 | 48,178 | ||
| Total liabilities: | 74,221 | 56,629 | 59,887 | 63,865 | 67,407 | 68,396 | 65,841 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | 182,237 | 179,976 | 176,318 | 171,990 | 169,188 | 166,119 | 163,375 | ||
| Common stock | 93 | 93 | 93 | 92 | 93 | 94 | 95 | ||
| Treasury stock, value | (147) | (82) | |||||||
| Additional paid in capital | 2,146 | 1,824 | 1,494 | 52 | 1,250 | 4,026 | 5,879 | ||
| Accumulated other comprehensive loss | (487) | (569) | (591) | (430) | (514) | (396) | (458) | ||
| Retained earnings | 180,485 | 178,628 | 175,322 | 172,276 | 168,506 | 162,477 | 157,859 | ||
| Total stockholders' equity: | 182,237 | 179,976 | 176,318 | 171,990 | 169,188 | 166,119 | 163,375 | ||
| TOTAL LIABILITIES AND EQUITY: | 256,458 | 236,605 | 236,205 | 235,855 | 236,595 | 234,515 | 229,216 | ||
Income Statement (P&L) ($ in thousands) Annual | Quarterly
| 6/30/2017 Q3 | 3/31/2017 Q2 | 12/31/2016 Q1 | 9/30/2016 Q4 | 6/30/2016 Q3 | 3/31/2016 Q2 | 12/31/2015 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues (Revenue, Net) | 64,993 | 61,215 | 56,619 | 56,701 | 60,836 | 59,492 | 55,959 | |
| Cost of revenue (Cost of Goods and Services Sold) | (31,600) | (30,140) | (27,679) | (28,509) | (29,416) | (29,163) | (27,851) | |
| Gross profit: | 33,393 | 31,075 | 28,940 | 28,192 | 31,420 | 30,329 | 28,108 | |
| Operating expenses | (29,174) | (23,919) | (22,173) | (21,888) | (22,883) | (22,778) | (21,323) | |
| Operating income: | 4,219 | 7,156 | 6,767 | 6,304 | 8,537 | 7,551 | 6,785 | |
| Interest and debt expense | (380) | (312) | (330) | (330) | (326) | (322) | (274) | |
| Income from continuing operations before income taxes: | 3,839 | 6,844 | 6,437 | 5,974 | 8,211 | 7,229 | 6,511 | |
| Income tax expense | (1,982) | (2,382) | (2,236) | (2,204) | (2,182) | (2,611) | (2,270) | |
| Net income available to common stockholders, diluted: | 1,857 | 4,462 | 4,201 | 3,770 | 6,029 | 4,618 | 4,241 | |
Comprehensive Income ($ in thousands)Annual | Quarterly
| 6/30/2017 Q3 | 3/31/2017 Q2 | 12/31/2016 Q1 | 9/30/2016 Q4 | 6/30/2016 Q3 | 3/31/2016 Q2 | 12/31/2015 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net income: | 1,857 | 4,462 | 4,201 | 3,770 | 6,029 | 4,618 | 4,241 | |
| Comprehensive income: | 1,857 | 4,462 | 4,201 | 3,770 | 6,029 | 4,618 | 4,241 | |
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 82 | 22 | (161) | 84 | (118) | 62 | (79) | |
| Comprehensive income, net of tax, attributable to parent: | 1,939 | 4,484 | 4,040 | 3,854 | 5,911 | 4,680 | 4,162 | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.